Search the Newsreel

ZIM Integrated Shipping Services (ZIM) Outperforms Broader Market: What You Need to Know

ZIM Integrated Shipping Services (ZIM) ended the recent trading session at $26.90, demonstrating a +1.97% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.62%. Elsewhere, the Dow gained 0.28%, while the tech-heavy Nasdaq added 1.3%. Heading …

Wilsey Asset Management Inc. Has $36.32 Million Stake in Zimmer Biomet Holdings, Inc. $ZBH

Wilsey Asset Management Inc. increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 4.7% in the second quarter, bringing its total holdings to 421,867 shares valued at $36.32 million. The medical equipment provider recently reported strong Q2 earnings, beating analyst estimates with $2.18 …

Zim Laboratories Q1FY27: Net loss widens to ₹401.70 lakh despite 31% revenue growth

Zim Laboratories makes Q1 FY27 earnings call audio available

Zimmer Biomet Holdings (ZBH) Following Its Beat And Guidance Lift, Is The Valuation Catching Up?

Zimmer Biomet Holdings (ZBH) recently reported stronger-than-expected quarterly results and increased its guidance, driven by solid execution in U.S. hip and technology lines and sales force restructuring progress. Despite a significant 5-year decline in shareholder return, the company's recent 90-day share price return of …

Zimmer Biomet (ZBH) Stock Gets Fair Value Bump After Mixed Analyst Views

Zimmer Biomet Holdings (ZBH) has seen its fair value updated by analysts, with some taking a bullish stance due to undervaluation and growth opportunities, while others remain cautious, emphasizing consistent execution and margin stabilization. The company's fair value moved from US$98.70 to approximately US$102.19, …

Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Raised to $104.9, Implies 7% Upside

Zimmer Biomet Holdings, Inc.'s average price target has been increased to $104.9, up from $104.26, according to 20 analysts. This updated target suggests a potential 7% upside based on the Aug. 5 closing price. The consensus rating among 29 analysts remains a "Buy," with …

JPMorgan Adjusts Price Target on Zimmer Biomet to $117 From $95

JPMorgan has raised its price target for Zimmer Biomet Holdings, Inc. (ZBH) to $117 from $95. This adjustment was reported on August 6, 2026, at 12:02 pm EDT. The article also notes several other analyst adjustments for Zimmer Biomet on the same day.

UBS Adjusts Price Target on Zimmer Biomet to $120 From $115, Maintains Buy Rating

UBS has increased its price target for Zimmer Biomet Holdings, Inc. (ZBH) to $120 from $115, while reaffirming a Buy rating on the stock. This adjustment comes amidst other analyst revisions for Zimmer Biomet on the same day, indicating active re-evaluation of the company's …

Zimmer Biomet sales force revamp going better than expected, CEO says

Zimmer Biomet's CEO Ivan Tornos announced that the company's transition to a fully dedicated sales force is progressing better than anticipated, leading to increased sales and earnings expectations for 2026. The restructuring, involving a shift of 2,500 U.S. sales personnel to dedicated specialists, has …

Deutsche Bank Adjusts Zimmer Biomet Price Target to $98 From $88, Maintains Hold Rating

Deutsche Bank has adjusted its price target for Zimmer Biomet Holdings, Inc. (ZBH) to $98, up from $88, while maintaining a "Hold" rating on the stock. This update reflects recent market activity and analyst assessments. The article also notes other analyst revisions for Zimmer …

Zimmer Biomet (ZBH) Stock Gains Ground While Margins Tighten

Zim Laboratories reports consolidated net loss of Rs 4.02 crore in the June 2026 quarter

ZIMMER BIOMET HOLDINGS, INC. : STIFEL RAISES TARGET PRICE TO $110 FROM $105

Stifel has increased its target price for Zimmer Biomet Holdings, Inc. (ZBH.N) to $110 from $105. This adjustment reflects a change in the financial outlook or valuation assessment by the analyst firm for the medical technology company. The article, sourced from Reuters, reports this …

ZIM (ZIM) Stock May Be 25% Undervalued After Australia Deal Clearance

ZIM Integrated Shipping Services (ZIM) stock shows mixed signals, with a Discounted Cash Flow (DCF) model suggesting it is undervalued by approximately 25% compared to its current price, especially after Australia cleared Hapag Lloyd's acquisition. However, market-based multiples indicate the stock is expensive, trading …

Earnings Flash (ZBH) Zimmer Biomet Holdings, Inc. Posts Q2 Adjusted EPS $2.07 per Share, Vs. FactSet Est of $2.01

Zimmer Biomet Holdings, Inc. (ZBH) reported strong second-quarter adjusted earnings per share of $2.07, surpassing the FactSet estimate of $2.01. The company's revenue also exceeded expectations, coming in at $1.85 billion against an estimated $1.81 billion. This positive performance indicates a strong financial quarter …

Zimmer Biomet Holdings Inc (ZBH) (Q2 2026) Earnings Call Highlights: Strong Sales Beat and Raised Guidance Amid Strategic Investments

Zimmer Biomet Holdings Inc (ZBH) reported strong Q2 2026 results, exceeding expectations with $2.177 billion in net sales and 4% organic constant currency growth, primarily driven by robust US performance in the hips segment and technology. The company raised its full-year 2026 revenue and …

Zimmer Biomet (NYSE: ZBH) awards 10,168 RSUs to President, APAC

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has awarded 10,168 restricted stock units (RSUs) to Chintan Desai, President, APAC. These RSUs represent a contingent right to one share of common stock each, with one-third vesting on August 3rd of 2027, 2028, and 2029. Following this …

Needham reiterates Hold on Zimmer Biomet stock after Q2 beat

Needham has reiterated a Hold rating on Zimmer Biomet Holdings Inc. (NYSE:ZBH) after the medical device company surpassed second-quarter revenue and EPS expectations. Despite strong gross profit margins and anticipated net income growth, the firm maintains its Hold rating due to expected challenges in …

Is ZIM Integrated Shipping Services (NYSE:ZIM) Still A Bargain Or Fully Priced?

ZIM Integrated Shipping Services (NYSE:ZIM) has seen a strong 220.5% return over three years, but its valuation signals are mixed. While a Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 21.6%, earnings-based multiples indicate it is expensive compared to the industry. …

Zimmer Biomet Holdings Releases Q2 2026 Financial Results

Zimmer Biomet Holdings reported strong Q2 2026 financial results, surpassing Wall Street expectations with adjusted earnings of $2.07 per share and revenue of $2.18 billion. The medical technology company showed consistent growth across its product lines and provided a full-year adjusted EPS projection of …

Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook

Zimmer Biomet has reported Q2 revenues of around $2.18bn, denoting a year-over-year (YoY) uptick of 4.8%, and a revised full year outlook. Zimmer's knees segment was its strongest performer in Q2, with sales totalling $828.9m, followed by S.E.T. (Sports Medicine, Extremities, Trauma, Craniomaxillofacial and …

[ZBH Q2 2026 Earnings Call] Zimmer Biomet Beats and Raises as Hip, Tech Sales Surge; U.S. Technology Revenue Jumps 53%

Zimmer Biomet exceeded Q2 2026 expectations, driven by strong hip and technology sales, leading to a raised full-year guidance. The company reported a 4.8% increase in net sales and a 53% jump in U.S. technology revenue, alongside significant growth in hip sales. CEO Iván …

Earnings call transcript: Zimmer Biomet lifts 2026 outlook after Q2 beat

Zimmer Biomet (ZBH) reported strong second-quarter 2026 results, beating Wall Street expectations for both earnings and revenue, leading the company to raise its full-year 2026 outlook. The orthopedic-device maker saw significant growth in hip sales, technology and data, and its S.E.T. business, with its …

Transcript : Zimmer Biomet Holdings, Inc., Q2 2026 Earnings Call, Aug 05, 2026

This article provides the transcript of Zimmer Biomet Holdings, Inc.'s Q2 2026 Earnings Call from August 5, 2026. The content is primarily a record of the conference call proceedings, including the operator's message and an invitation for subscribers to access the full transcript. The …

Zimmer (ZBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zimmer Biomet (ZBH) reported $2.18 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 4.8%. EPS of $2.07 for the same period compares to $2.07 a year ago. The reported revenue represents a surprise of +2.25% over the Zacks …

Zimmer Biomet raises full-year outlook after second-quarter earnings beat

Researcher looking through microscope ©Adobe Stock Images Zimmer Biomet Holdings (NYSE:ZBH) reported better-than-expected second-quarter results and increased its guidance for the full year, helping lift the medical technology company's shares more than 4% in pre-market trading. The company posted adjusted earnings of $2.07 per …

Zimmer Biomet stock rises 4% on Q2 beats, raised guidance By Investing.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported stronger-than-expected second-quarter results and subsequently raised its full-year guidance, leading to a 4.27% increase in pre-market trading. The medical technology company surpassed analyst consensus for both adjusted earnings per share and revenue. This positive performance was attributed to …

Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates

Zimmer Biomet (ZBH) reported strong Q2 results, with earnings of $2.07 per share and revenues of $2.18 billion, both exceeding Zacks Consensus Estimates. The company has consistently surpassed EPS estimates over the last four quarters and revenues three times. Despite underperforming the market year-to-date, …

Zimmer Biomet Q2 Adjusted Earnings Flat, Net Sales Rise; Lifts 2026 Guidance

Zimmer Biomet Holdings reported flat adjusted earnings for Q2 2026 but saw an increase in net sales. The company also raised its 2026 financial guidance following strong implant demand. Several analysts have adjusted their price targets for Zimmer Biomet in response to the earnings …

Zimmer Biomet’s (NYSE:ZBH) Q2 CY2026: Beats On Revenue

Zimmer Biomet (NYSE:ZBH) reported better-than-expected revenue in Q2 CY2026, with sales up 4.8% year-on-year to $2.18 billion, beating analyst estimates. The company's non-GAAP profit of $2.07 per share also surpassed estimates by 3%, and management slightly raised its full-year Adjusted EPS guidance. While the …

Press Release: Zimmer Biomet Announces Second Quarter 2026 Financial Results

Zimmer Biomet announced its financial results for the second quarter of 2026. The company is providing a press release detailing its performance for the quarter. This release will offer insights into the company's financial health and operational achievements.

Zimi Limited Issues 1,923,077 Shares to Settle Supplier Invoice

Zimmer Biomet (NYSE: ZBH) lifts Q2 2026 earnings and cash flow

Zimmer Biomet Gets FDA 510(k) Clearance for Next-Gen ROSA Shoulder System

Zimi Limited Applies to Quote 1,923,077 Ordinary Shares Issued for Part Settlement of Invoice